Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1995
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L04AA06
|
| gptkbp:CASNumber |
128794-94-5
|
| gptkbp:chemicalFormula |
C23H31NO7
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to mycophenolate mofetil |
| gptkbp:drugClass |
immunosuppressant
|
| gptkbp:eliminationHalfLife |
16-18 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:genericName |
gptkb:mycophenolate_mofetil
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cellcept
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
inhibits inosine monophosphate dehydrogenase
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting diarrhea leukopenia increased risk of infection |
| gptkbp:usedFor |
prevention of organ transplant rejection
treatment of lupus nephritis |
| gptkbp:bfsParent |
gptkb:Roche
|
| gptkbp:bfsLayer |
6
|